Oncotarget
ISSN: 1949-2553
Publisher: Impact Journals
Publications (110)
Sulforaphane inhibits growth and blocks Wnt/β-catenin signaling of colorectal cancer cells (2018)
Bernkopf D, Daum G, Brückner M, Behrens J
Journal article
Chemical exchange saturation transfer MRI serves as predictor of early progression in glioblastoma patients (2018)
Regnery S, Adeberg S, Dreher C, Oberhollenzer J, Meissner JE, Goerke S, Windschuh J, et al.
Journal article, Original article
Serum levels of miR-320 family members are associated with clinical parameters and diagnosis in prostate cancer patients (2018)
Lieb V, Weigelt K, Scheinost L, Fischer K, Greither T, Marcou M, Theil G, et al.
Journal article
Subclassification, survival prediction and drug target analyses of chemotherapy-naïve muscle-invasive bladder cancer with a molecular screening (2018)
Rinaldetti S, Rempel E, Worst TS, Eckstein M, Steidler A, Weiss CA, Bolenz C, et al.
Journal article
Characterization and diagnostic application of genomic NPM-ALK fusion sequences in anaplastic large-cell lymphoma (2018)
Krumbholz M, Woessmann W, Zierk J, Seniuk D, Ceppi P, Zimmermann M, Singh VK, et al.
Journal article
Combined effects of PLK1 and RAS in hepatocellular carcinoma reveal rigosertib as promising novel therapeutic "dual-hit" option (2018)
Dietrich P, Freese K, Mahli A, Thasler WE, Hellerbrand C, Boßerhoff AK
Journal article
Selenium-binding protein 1 is down-regulated in malignant melanoma (2018)
Schott M, de Jel MM, Engelmann JC, Renner P, Geissler EK, Boßerhoff AK, Kuphal S
Journal article
Real world experience in low-dose ipilimumab in combination with PD-1 blockade in advanced melanoma patients (2018)
Kirchberger MC, Moreira A, Erdmann M, Schuler G, Heinzerling L
Journal article
A multicenter round robin test of PD-L1 expression assessment in urothelial bladder cancer by immunohistochemistry and RT-qPCR with emphasis on prognosis prediction after radical cystectomy (2018)
Eckstein M, Wirtz RM, Pfannstil C, Wach S, Stoehr R, Breyer J, Erlmeier F, et al.
Journal article
The outweigh of toxicity versus risk of recurrence for adjuvant interferon therapy: a survey in German melanoma patients and their treating physicians (2018)
Kähler KC, Blome C, Forschner A, Gutzmer R, Hauschild A, Heinzerling L, Livingstone E, et al.
Journal article